EP 1161237 A1 20011212 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASE-INHIBITOREN
Title (fr)
INHIBITEURS DE PROTEASE
Publication
Application
Priority
- US 0006888 W 20000316
- US 12465999 P 19990316
Abstract (en)
[origin: WO0054769A1] The present invention provides 7-membered ring 1,3-dioxepin-5-one protease inhibitors, particularly such inhibitors of cysteine and serine proteases, and methods of treating diseases which may be therapeutically modified by altering the activity of such proteases.
IPC 1-7
IPC 8 full level
C07D 407/12 (2006.01); A61K 31/357 (2006.01); A61P 1/02 (2006.01); A61P 19/00 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07D 321/06 (2006.01); C07D 409/12 (2006.01)
CPC (source: EP)
A61P 1/02 (2017.12); A61P 19/00 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 29/00 (2017.12); A61P 43/00 (2017.12); C07D 321/06 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0054769 A1 20000921; AR 022927 A1 20020904; AU 3888200 A 20001004; CO 5180542 A1 20020730; EP 1161237 A1 20011212; EP 1161237 A4 20020327; HK 1043534 A1 20020920; JP 2002539160 A 20021119; PE 20001564 A1 20010208; UY 26026 A1 20001031
DOCDB simple family (application)
US 0006888 W 20000316; AR P000101121 A 20000314; AU 3888200 A 20000316; CO 00019250 A 20000316; EP 00917997 A 20000316; HK 02103606 A 20020513; JP 2000604845 A 20000316; PE 0002262000 A 20000316; UY 26026 A 20000223